Effect of gamma linolenic acid pretreatment on diabetic neuropathy in rats
Keywords:Diabetic neuropathy, Gamma linolenic acid, STZ, MNCV, Hyperalgesia
Background: The present study was planned to evaluate the preventive effects of gamma linolenic acid (GLA) on STZ induced diabetic neuropathy
Methods: Streptozotocin (STZ) induced diabetic neuropathy in rats was monitored by measuring blood sugar levels, body weight, motor nerve conduction velocity (MNCV) and nociception. Forty rats were divided into 4 groups of 10 each. Group 1: control (vehicle), Group 2: STZ (50 mg/kg, i.v., single injection), Group 3: Gamma linolenic acid (50 mg/ kg, p.o., daily + STZ), Group 4: STZ + Insulin (4 units/kg, s.c., bid). Similar protocol was used for other parameters also.
Results: Gamma linolenic acid pretreatment failed to reduce blood sugar levels in diabetic rats but prevented deterioration of motor nerve conduction velocity as compared to STZ diabetic rats. A significant weight gain was observed in STZ diabetic rats pretreated with GLA as compared to rats received STZ alone. Hyperalgesia induced by STZ was antagonized by GLA
Conclusions: Thus gamma linolenic acid prevents the development of neuropathic changes induced by STZ in rats.
Zimmy S, Sehatz H, Pfohl M. The role of limited joint mobility in diabetic patients with an at risk foot. Diabetes Care 2004;27:942-6.
Thomas PK, Tomlison DR. Diabetic and hypoglycemic neuropathy in Dyck PJ, Thomas PK, Griffin JW, Low PA, Pdulo JF (editors): Peripheral neuropathy. Philadelphia, Saunnders; 1993:1219-50.
Sima AA, Greene DA. Diabetic neuropathy in elderly. Drugs Aging 1995;6:125-35.
McCarty MF. Nitric oxide deficiency, leukocyte activation and resultant ischemia area critical to the pathogenesis of diabetic retinopathy/ neuropathy – preventive potential of antioxidants, essential fatty acids, chromium, ginkgolides and pentoxifylline. Med Hypotheses 1998;50:435-49.
Vinik AI, Erbas T, Sansberry KB. Small fiber neuropathy and neurovascular disturbances in diabetes mellitus. Exp Clin Endocrinol Diabetes 2001;109(suppl.2):s451-73.
Mancuso JM. Impact of health literacy and patient trust on glycemic control in an urban population. Nurs Health Sci 2010;12:94-104.
Lee NY, Kang YS. Regulation of taurine transport at the blood placental barrier by calcium ion, PKC activator and oxidative stress conditions. J Biomed Sci 2010;17(suppl1):s37.
Nicolucci A, Crici F, Cavaliere D. A meta-analysis of trials of aldose reductase inhibitor in diabetic peripheral neuropathy. Diabet Med 1996;13:1017-26.
Omran OM. Histopathological study of evening primrose oil effects on experimental diabetic neuropathy. Ultrastruct Pathol 2012;36:222-7.
Benatti P, Peluso G, Nicolai R, Calvani M. Polysaturated fatty acids: biochemical, nutritional and epigastric properties. J Am Cell Nutr 2004;23:281-302.
Carter JP. Gamma linolenic acid as a nutrient. Food Tech 1998;42:72-82.
Zurier RB, Rosseti RA, Jacobson EW, De Marco DM, Liu NY, Tenming JE, et al. Gamma linolenic acid treatment of rheumatoid arthritis. A randomized, placebo controlled trial. Arthritis Rheum 1996;39:1808-17.
Andereassi M, Forleo P, Di- Lorio A. Efficacy of gamma linolenic acid in the treatment of patients with atopic dermatitis. J Int Med Res 1997;25:266-74.
Pacht ER, DeMichele SJ, Nelson JL. Enteral nutrition with eicosopentaenoic acid, gamma linolenic acid and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Crit Care Med 2003;31:491-500.
Surette ME, Koomenis IL, Edens MB. Inhibition of leucotrine biosynthesis by a novel dietary fatty acid formulation in patients with ectopic asthma: a randomized, placebo controlled, parallel group, prospective trial. Clin Ther 2003;25:972-9.
Middleton SJ, Naylor S, Wodner J, Hunter JO. A double blind randomized placebo controlled trial of essential fatty acid supplementation in the maintenance of remission of ulcerative colitis. Aliment Pharmacol Ther 2002;16:1131-50.
Kenny FS, Gee JM, Nichalson RI. Effect of dietary GLA + tamoxifen on the growth, ER expression and fatty acid profile of ER positive breast cancer xenograft. Int J Cancer 2001;92:342-7.
Kruger MC, Coetzer H, de winter R, et al. Calcium, gamma linolenic acid and eicosapentanoic acid supplementation in senile osteoporosis. Aging (Milano) 1998;10:385-94.
Keen H, Payan J, Allawi J, Walker J, Jamal GA, Weir AI. Treatment of diabetic neuropathy with gamma linolenic acid. The gamma linolenic acid multicenter trial group. Diabetes Care 1993;16:8-15.
Suresh Y, Das UN. Long chain polyunsaturated fatty acids and chemically induced diabetes mellitus. Effects of omega- 6 fatty acids. Nutrition 2003;19:93-114.
Brenner RR. Nutritional and hormonal factors influencing desaturation of essential fatty acids. Prog Lipid Res 1982;20:41-7.
Trinder P. Enzymatic determination of blood glucose. Ann Clin Biochem 1969;6:24-8.
DE Koning P, Gispen WH. Org.2766 improves functional and electrophysiological aspects of regenerating sciatic nerve in the rat. Peptides 1987;8:415-22.
Davies OL, Ranventos J, Walpole AL. Methods for evaluation of analgesic activity using rats. Br J Pharmacol Chemother 1946;1:255-64.
Musabayane CT, Tufts MA, Mapanga RF. Synergistic antihyperglycemic effects between plant-derived oleanolic acid and insulin in streptozotocin-induced diabetic rats. Ren Fail 2010;32:832-9.
Cermenati G, Affiati F, Cermenati S. Diabetes induced myelin abnormalities are associated with an altered lipid pattern: protective effects of LXR activation. J Lipid Res 2012;53:300-10.
Srinivasan A, Menon VP, Pariaswamy V, Rajsekaran KN. Protection of pancreatic beta-cell by the potential antioxidant bis-o-hydroxycinnamoyl methane, analogue of natural curcuminoid in experimental diabetes. J Pharm Pharm Sci 2003;6:327-33.